Summary
The UK data watchdog is set to fine NHS vendor Advanced for security failures that occurred before the LockBit ransomware attack. These security lapses contributed to the vulnerability exploited during the attack.
The cyber attack had extensive repercussions, impacting the systems for dispatching ambulances, booking out-of-hours appointments, and issuing emergency prescriptions.
In a provisional ruling, the ICO stated that the software provider violated data protection laws by failing to secure personal information for 82,946 individuals.
These records were stolen in a ransomware attack by hackers who accessed Advanced's computer systems through an account that lacked multi-factor authentication (MFA).
Typically, MFA would have prevented cyber criminals from using stolen passwords to gain access.
The stolen data included sensitive information such as phone numbers, medical records, and details on how to access the properties of 890 people receiving home care.
Sign up for our newsletter
We like to keep our readers up to date on complex regulatory issues, the latest industry trends and updated guidelines to help you to solve a problem or make an informed decision.
Navigating Privacy Requirements for Clinical Trials Across Jurisdictions: Focus on China
China’s data protection regulations play a crucial role in clinical trials, requiring sponsors and researchers to comply with multiple laws, including the PIPL, GCP-2020, and cross-border data transfer rules. Unlike other jurisdictions, China imposes strict consent requirements, risk assessments, and regulatory filings, making compliance a key factor when selecting trial locations and managing participant data.
Addressing the Data Protection and Ethical Challenges posed by AI in Health – Part I
Analyzing the Similarities and Differences Between ICH-GCP and GDPR in Clinical Trials
ICH-GCP and GDPR are vital for clinical trials, setting standards for participant protection and data integrity, with distinct focuses and enforcement approaches.
